The LancetVolume 384, Issue 9955, 8–14 November 2014, Page 1667CorrespondenceRandomisation is essential in Ebola drug trialsAuthor links open overlay panelDavid Shaw aShow moreShareCitehttps://doi.org/10.1016/S0140-6736(14)61735-9Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View AbstractCopyright © 2014 Elsevier Ltd. All rights reserved.